Altrova Health Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Apr '23 Apr 30, 2023
Net Income	-4.4	-4.28	-5.02	-9.46	-3.47
Depreciation & Amortization	0.02	0	0	-	-
Other Amortization	-	-	-	5.51	-
Loss (Gain) From Sale of Assets	0.07	0.07	-	-	-
Asset Writedown & Restructuring Costs	2.49	2.49	-	-	-
Loss (Gain) From Sale of Investments	0.03	0.03	0.34	-	-
Stock-Based Compensation	0.45	0.36	1.68	-	-
Provision & Write-off of Bad Debts	0.01	0.01	0.36	-	-
Other Operating Activities	-0.98	0.09	-0	0.01	-
Change in Accounts Receivable	-0.12	-0.1	-0.21	-0.21	-
Change in Accounts Payable	1.22	0.02	-0.48	2.92	2.51
Change in Other Net Operating Assets	0.33	0.35	0.3	-0.16	1.35
Operating Cash Flow	-0.89	-0.96	-3.04	-1.39	0.38
Capital Expenditures	-	-	-0.02	-	-
Cash Acquisitions	0.51	0.01	-	3.25	-
Investment in Securities	0.05	-	-0.44	-	-
Investing Cash Flow	0.2	0.01	-0.46	3.25	-
Issuance of Common Stock	1.18	0.79	0.13	4.63	3.7
Other Financing Activities	-0.12	-0.05	-	-0.83	-0.38
Financing Cash Flow	1.06	0.74	0.13	3.8	3.31
Net Cash Flow	0.37	-0.21	-3.37	5.66	3.7
Free Cash Flow	-0.89	-0.96	-3.06	-1.39	0.38
Free Cash Flow Margin	-3005.98%	-3255.27%	-	-	-
Free Cash Flow Per Share	-0.01	-0.01	-0.04	-0.04	-
Levered Free Cash Flow	-0.01	-0.24	-2.38	-	-
Unlevered Free Cash Flow	-0.01	-0.24	-2.38	-	-
Change in Working Capital	1.44	0.27	-0.39	2.55	3.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.